Product logins

Find logins to all Clarivate products below.


ENT Devices | Market Insights | Europe | 2022

The COVID-19 pandemic will have a significant impact on ENT procedure volumes in the short term. Once the market stabilizes, however, ENT procedure volumes will grow only slightly in Europe through 2030,hampered by growing developments in alternative treatment such as antibiotics and continued effort of various associations to promote alternatives to surgery. However, ongoing adoption of premium-priced devices, innovative devices such as Eustachian tube balloon dilation devices, and a general trend toward flexible endoscopy will drive the minimal growth of this market through 2030.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for ENT devices in Europe across an 11-year period.

Related Medtech Insights Reports

Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Diabetes Care Devices – Market Insights – Europe
The European diabetes care device market will grow moderately over the forecast period, driven by a rising diabetes population, favorable reimbursement policies, ongoing device innovation, and the…
Report
Cardiac Assist Devices – Market Insights – Europe
The European cardiac assist device market, although encumbered by recurring device recalls, will continue to grow rapidly due to new product development, expanded use across a broader patient…